QuidelOrtho (NASDAQ:QDEL – Get Free Report) and United Health Products (OTCMKTS:UEEC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.
Risk and Volatility
QuidelOrtho has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.89, suggesting that its stock price is 189% less volatile than the S&P 500.
Earnings & Valuation
This table compares QuidelOrtho and United Health Products”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QuidelOrtho | $2.73 billion | 0.37 | -$1.13 billion | ($16.66) | -0.89 |
| United Health Products | N/A | N/A | -$2.00 million | ($0.02) | -2.35 |
United Health Products has lower revenue, but higher earnings than QuidelOrtho. United Health Products is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 0.1% of United Health Products shares are owned by institutional investors. 0.8% of QuidelOrtho shares are owned by company insiders. Comparatively, 1.5% of United Health Products shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares QuidelOrtho and United Health Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QuidelOrtho | -41.46% | 5.91% | 2.37% |
| United Health Products | N/A | N/A | -2,141.74% |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for QuidelOrtho and United Health Products, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QuidelOrtho | 3 | 2 | 1 | 0 | 1.67 |
| United Health Products | 0 | 0 | 0 | 0 | 0.00 |
QuidelOrtho currently has a consensus target price of $31.50, indicating a potential upside of 113.13%. Given QuidelOrtho’s stronger consensus rating and higher possible upside, equities research analysts clearly believe QuidelOrtho is more favorable than United Health Products.
Summary
QuidelOrtho beats United Health Products on 9 of the 13 factors compared between the two stocks.
About QuidelOrtho
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
Receive News & Ratings for QuidelOrtho Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuidelOrtho and related companies with MarketBeat.com's FREE daily email newsletter.
